Novaliq GmbH said yesterday that it named Christian Roesky as its new CEO, replacing co-founder Bernhard Günther, who will take on a new role as chief innovation officer. The Heidelberg, Germany-based company focuses on renovating poorly soluble drugs into effective ocular therapeutics. Its CE-marked product, NovaTears, was developed from its proprietary EyeSol technology. With its […]
Nanoparticles deliver engineered protein to prevent joint damage
Researchers at Washington University have developed nanoparticles to treat the inflammation that wears away at joint cartilage in patients with osteoarthritis. Traditional treatment methods to reduce inflammation involve steroid injections, but the body quickly washes them away, leaving the cells vulnerable to more inflammation. “I see a lot of patients with osteoarthritis, and there’s really […]
CMS finds Mylan overcharged Medicaid for EpiPens for years
The Centers for Medicare & Medicaid Services said this week that Mylan Pharmaceuticals (NSDQ:MYL) has been overcharging Medicaid for its EpiPen auto-injector for years, despite being warned that it should have paid bigger rebates. CMS said that between 2011 and 2015, Medicaid spent $797 million on the epinephrine auto-injector after deducting rebates, marking the 1st […]
‘Connectosomes’ efficiently deliver chemo to targeted cells
Researchers have developed a new form of nanoparticles called “connectosomes” that can efficiently deliver chemotherapy to human cells more efficiently than traditional delivery methods, according to a report out of the University of Texas at Austin. The team, who published their research in the Journal of the American Chemical Society, equipped the connectosomes with gap junctions […]
AngioSoma taps La Jolla Capital for Liprostin JV
AngioSoma (OTCQB:SOAN) said today that it landed a joint venture with La Jolla Capital to help fund and manage phase III trials studying its flagship product, Liprostin. The Montgomery, Texas-based company has completed 1 phase I and 3 phase II clinical trials evaluating its lead pharmaceutical candidate. Liprostin is a liposomal encapsulated prostaglandin, developed to […]
Report: Drug device market to reach $1.8B by 2024
The global drug device combination market is expected to reach $17.7 billion by 2024, according to a new report from Grand View Research. The report points to minimally invasive alternatives like transdermal patches as high-impact growth drivers in the industry. As researchers develop these products, regulatory agencies have taken notice and the report notes that […]
Motion-directed microrobots for targeted drug delivery
Researchers have created tiny ‘microbots’ that are able to move and react in a fashion similar to bacteria, according to a report from the Max Planck Institute for Intelligent Systems. Bacteria use flagella to move, directed by stimuli like sources of light or the earth’s magnetic field. Researchers have developed synthetic microrobots with motility and phototaxis, […]
Enable Injections lands $30m Series A for large-volume injector
Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s body and delivers biologic doses as large as 50 milliliters. It can be used at work or at home, providing an alternative to costly […]
Nobel chemistry prize goes to molecular machinery
A group of European scientists won the 2016 Nobel Prize for chemistry for developing the “world’s smallest machines” that could be used for drug delivery. Jean-Pierre Sauvage, J. Fraser Stoddart and Bernard Feringer claimed the $931,000 prize (8 million Swedish crowns) for work that Feringer described as having “endless” potential, according to Reuters. “Think of […]
Royal Philips debuts Volcano tech in Canada
Royal Philips (NYSE:PHG) said today that it debuted its Volcano catheter-based imaging and measurement systems for minimally invasive diagnostics and treatment of cardiovascular disease in Canada. Eighty-five percent of Canadian hospitals use Philips cardiology solutions, according to the Netherlands-based company. Its imaging and navigation systems provide direction for clinicians to guide catheters to an area of interest […]
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and a 510(k) submission. The New York-based company is developing smart injection devices and software to monitor patient adherence to clinical trial and daily regimens. Average adherence rates […]